Masimo Corp. (MASI)

97.07
NASDAQ : Health Technology
Prev Close 96.77
Day Low/High 96.72 / 97.80
52 Wk Low/High 80.69 / 100.00
Avg Volume 525.00K
Exchange NASDAQ
Shares Outstanding 51.78M
Market Cap 4.98B
EPS 2.50
P/E Ratio 43.01
Div & Yield N.A. (N.A)

Latest News

Masimo UniView™ (Photo: Business Wire)

Masimo UniView™ (Photo: Business Wire)

Masimo (NASDAQ: MASI) announced today the release of UniView™, an integrated display of real-time data and alarms from multiple Masimo and third-party devices, designed to reduce clinician cognitive overload and...

Masimo Radical-7® With SpHb®, PVi®, And RD Rainbow SET™ Sensor (Photo: Business Wire)

Masimo Radical-7® With SpHb®, PVi®, And RD Rainbow SET™ Sensor (Photo: Business Wire)

Masimo (NASDAQ: MASI) announced today the findings of a recently published study in which researchers at Cairo University in Egypt evaluated the accuracy and trending of Masimo noninvasive and continuous hemoglobin...

Masimo To Present At Barclays Global Healthcare Conference

Masimo To Present At Barclays Global Healthcare Conference

Masimo (NASDAQ: MASI) today announced that its management is scheduled to present at the Barclays Global Healthcare Conference at the Loews Miami Beach Hotel on Tuesday, March 13, 2018 at 4:20 p.

Masimo Replica™ (Photo: Business Wire)

Masimo Replica™ (Photo: Business Wire)

Today at the 2018 HIMSS Annual Conference, Masimo (NASDAQ: MASI) announced the release of Replica™, an application for smart phones and tablets that works in conjunction with Masimo Patient SafetyNet™*, a...

Masimo To Present At 39th Annual Raymond James Institutional Investors Conference

Masimo To Present At 39th Annual Raymond James Institutional Investors Conference

Masimo (NASDAQ: MASI) today announced that its management is scheduled to present at the 39th Annual Raymond James Institutional Investors Conference at the Marriott Grande Lakes in Orlando on Wednesday, March 7,...

Masimo Reports Fourth Quarter 2017 Financial Results

Masimo Reports Fourth Quarter 2017 Financial Results

Masimo (NASDAQ: MASI) today announced its financial results for the fourth quarter ended December 30, 2017.

Leading Nephrology Care Center In India Adopts Masimo Technologies Across Continuum Of Care

Leading Nephrology Care Center In India Adopts Masimo Technologies Across Continuum Of Care

Masimo (NASDAQ: MASI) announced today that NU Hospitals, a leading nephrology care center in India, has standardized on Masimo technologies across the continuum of care.

Masimo Radical-7® With SpHb® (Photo: Business Wire)

Masimo Radical-7® With SpHb® (Photo: Business Wire)

Masimo (NASDAQ: MASI) announced today the findings of a recently published study in which researchers at Michigan State University evaluated the performance of noninvasive hemodynamic monitoring (NIHM) using Masimo...

Masimo Radical-7® Pulse CO-Oximeter® With Rainbow SET™ PVi® (Photo: Business Wire)

Masimo Radical-7® Pulse CO-Oximeter® With Rainbow SET™ PVi® (Photo: Business Wire)

Masimo (NASDAQ: MASI) announced today the findings of a recently published study in which researchers at Bülent Ecevit University in Zonguldak, Turkey compared two noninvasive methods of predicting fluid...

Masimo Rad-97™ With Eve™ (Photo: Business Wire)

Masimo Rad-97™ With Eve™ (Photo: Business Wire)

Masimo (NASDAQ: MASI) announced today the CE marking of Eve™, a critical congenital heart disease (CCHD) newborn screening application, for the Rad-97™ Pulse CO-Oximeter ®.

Masimo To Report Fourth Quarter And Full Year 2017 Financial Results After Market Close On Tuesday, February 27

Masimo To Report Fourth Quarter And Full Year 2017 Financial Results After Market Close On Tuesday, February 27

Masimo (NASDAQ: MASI) announced today that it will release fourth quarter and full year 2017 financial results for the period ended December 30, 2017, after the market closes on Tuesday, February 27, 2018.

Masimo Root® With Next Generation SedLine® Brain Function Monitoring (Photo: Business Wire)

Masimo Root® With Next Generation SedLine® Brain Function Monitoring (Photo: Business Wire)

Masimo (NASDAQ: MASI) announced today FDA clearance of Next Generation SedLine ® brain function monitoring.

New Study Investigates The Clinical Utility Of ORi™, Masimo Oxygen Reserve Index™, In Obese Patients

New Study Investigates The Clinical Utility Of ORi™, Masimo Oxygen Reserve Index™, In Obese Patients

Masimo (NASDAQ: MASI) announced today the findings of an abstract presented at the annual meeting of the Society for Technology in Anesthesia (STA) in Miami, Florida.

Patient Surveillance Using Masimo Patient SafetyNet™ (Photo: Business Wire)

Patient Surveillance Using Masimo Patient SafetyNet™ (Photo: Business Wire)

Masimo (NASDAQ: MASI) announced today FDA clearance for home use of the Rad-97™ Pulse CO-Oximeter ®.

Masimo To Present At 36th Annual J.P. Morgan Healthcare Conference

Masimo To Present At 36th Annual J.P. Morgan Healthcare Conference

Masimo (NASDAQ: MASI) today announced that its management is scheduled to present at the 36th Annual J.

Masimo RD Rainbow Lite SET™ Sensor (Photo: Business Wire)

Masimo RD Rainbow Lite SET™ Sensor (Photo: Business Wire)

Masimo (NASDAQ: MASI) announced today the CE marking and release of RD rainbow Lite SET™ sensors, which enable the monitoring of Masimo Oxygen Reserve Index™ (ORi™) and RPVi™, an improved...

Artemis Hospital Becomes First In India To Adopt Masimo Patient SafetyNet™ Across All Hospital Care Areas

Artemis Hospital Becomes First In India To Adopt Masimo Patient SafetyNet™ Across All Hospital Care Areas

Masimo (NASDAQ: MASI) announced today that Artemis Hospital, one of the leading multi-specialty hospitals in the Delhi-NCR region of India, is adopting Masimo Patient SafetyNet™*, a supplemental remote...

Masimo Root® Patient Monitoring And Connectivity Platform With NomoLine™ Capnography (Photo: Business Wire)

Masimo Root® Patient Monitoring And Connectivity Platform With NomoLine™ Capnography (Photo: Business Wire)

Masimo (NASDAQ:MASI) announced today FDA clearance and U.

Masimo Supports World Pneumonia Day Efforts

Masimo Supports World Pneumonia Day Efforts

In conjunction with World Pneumonia Day on Sunday, November 12, Masimo (NASDAQ: MASI) announced its continuing efforts to help combat the global burden of pneumonia.

Masimo To Present At Stifel 2017 Healthcare Conference

Masimo To Present At Stifel 2017 Healthcare Conference

Masimo (NASDAQ: MASI) today announced that its management is scheduled to present at the Stifel 2017 Healthcare Conference at the Palace Hotel in New York on Tuesday, November 14, 2017 at 9:30 a.

The Jeffrey Lee Williams Foundation Presents Masimo Rad-57® Pulse CO-Oximeters® To Members Of The Piedmont Medical Center EMS (York County, South Carolina) (Photo: Business Wire)

The Jeffrey Lee Williams Foundation Presents Masimo Rad-57® Pulse CO-Oximeters® To Members Of The Piedmont Medical Center EMS (York County, South Carolina) (Photo: Business Wire)

Masimo (NASDAQ: MASI) announced today that The Jeffrey Lee Williams Foundation has distributed 20 Masimo Rad-57 ® Pulse CO-Oximeters ® to EMS departments in York County, South Carolina, with the majority...

Masimo Reports Third Quarter 2017 Financial Results

Masimo Reports Third Quarter 2017 Financial Results

Masimo (NASDAQ: MASI) today announced its financial results for the third quarter ended September 30, 2017.

Masimo To Report Third Quarter 2017 Financial Results After Market Close On Tuesday, October 31

Masimo To Report Third Quarter 2017 Financial Results After Market Close On Tuesday, October 31

Masimo (NASDAQ: MASI) announced today that it will release financial results for the third quarter ended September 30, 2017, after the market closes on Tuesday, October 31, 2017.

San Diego Bankruptcy Court Rules Sotera Employees Misappropriated Masimo Trade Secrets

San Diego Bankruptcy Court Rules Sotera Employees Misappropriated Masimo Trade Secrets

Masimo (NASDAQ: MASI) announced today that the bankruptcy court in San Diego has issued final judgment, holding that Sotera Wireless Employees misappropriated Masimo trade secrets.

TheStreet Quant Rating: B+ (Buy)